Company overview
Basic information
Company name
Emarkmode, MB
Company code
306212194
VAT code
LT100016003015
Registered address
Marijampolė, Vasario 16-osios g. 10-48, LT-68301
Registration date
2023-01-05
Company age: 3 y. 8 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
MB "Emarkmode"
Company code: 306212194
Address: Marijampolė, Vasario 16-osios g. 10-48, LT-68301
VAT code: LT100016003015
Download a detailed company report
Make confident decisions with all the information about Emarkmode, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Emarkmode, MB (company code 306212194) is an operational private small partnership registered in 2023. The company is classified as a micro-sized entity in the sector of national private non-financial companies, with private ownership based on Lithuanian natural and legal persons and no foreign investor capital. Its governance structure is CEO only. The company is based in Marijampole, Marijampoles municipality, Marijampoles county, at Vasario 16-osios g. 10-48.
The company’s registered activity under EVRK code G.47.73.00 is retail sale of pharmaceutical products. Financially, Emarkmode reported revenue of EUR 156.5 thousand in 2025, up 45.2% year on year and 82.9% over two years. Net profit for 2025 was EUR 41.6 thousand, with a profit margin of 26.6%. Equity increased to EUR 72.4 thousand, total assets reached EUR 96.4 thousand, and liabilities were EUR 24.1 thousand. The company’s 2025 figures also indicate strong profitability relative to its asset base. Average employment stood at 1 person so far in 2026.
The company’s registered activity under EVRK code G.47.73.00 is retail sale of pharmaceutical products. Financially, Emarkmode reported revenue of EUR 156.5 thousand in 2025, up 45.2% year on year and 82.9% over two years. Net profit for 2025 was EUR 41.6 thousand, with a profit margin of 26.6%. Equity increased to EUR 72.4 thousand, total assets reached EUR 96.4 thousand, and liabilities were EUR 24.1 thousand. The company’s 2025 figures also indicate strong profitability relative to its asset base. Average employment stood at 1 person so far in 2026.